Terms and Conditions

This page describes the Terms and Conditions which apply to the Ipsen PCa Week (“Event”) organized by Ipsen Pharma Singapore Pte Ltd (“Ipsen”).

These Terms and Conditions apply to all Event attendees (“you”). In registering and or attending the Event, you confirm that you have read and agree to these Terms and Conditions (these “Terms and Conditions”) without reservation.

1. Background and Obligations of Event Attendees
   
  Ipsen or its affiliate or partner has invited you to attend the Event, which will be beneficial to the medical and scientific professionals in the field of Urology & Oncology.

This Event is limited to healthcare professionals. By attending the Event, you undertake, warrant and agree that you are a healthcare professional registered to practice in your country.

Ipsen or its affiliate or partner will not take charge of any expenses that you may incur in attending the Event. 

This invitation to attend the Event is not transferable to any other person.

You agree that invitation to attend the Event and your attendance at the Event has/have not and will not influence, and is not intended to influence, any decision you may make, or action you might take, regarding current or future business with, or on behalf of, Ipsen.

By attending the Event:

    • you agree that you will comply with all procedures, including obtaining approvals and/or disclose this invitation as required under the policies of your employer, professional codes of conduct applicable to you and applicable law and that Ipsen may disclose publicly and/or to any authorities this invitation; and
    • you confirm that your attendance at this Event fully complies with all applicable anti-bribery / anti-corruption laws and regulations.
   
2. Intellectual property
   
  The information and materials to be presented or provided during the Event (the “Materials”) is owned or licensed by Ipsen and or its affiliates. The presentation and each of the elements, including trademarks and logos appearing on the Materials are protected by intellectual property laws and (i) are held by Ipsen or its affiliates or (ii) are held by third parties and are subject to an authorization of use granted to Ipsen by their owners.

No part of the Materials may be copied, reproduced, modified, republished, uploaded, distorted, transmitted or distributed in any manner or in any medium, in part or in whole, without the prior written consent of Ipsen. Ipsen consent would be limited to copying for private usage for your personal, private and non-commercial use, on your personal computer. Elements composing or contained in the Materials authorized for use may not be distorted, modified or altered in any way.

Ipsen or its affiliates reserve the right to take legal action against any counterfeit of its intellectual property rights.
   
   
3. Nature of information
   
  As the case may be, the Event may include expert opinions concerning a particular area in relation with the content of the Material. Such information represents only the opinions of the respective experts, which opinions are not necessarily those of Ipsen. Such experts are not employees of Ipsen. Ipsen has engaged such experts for the performance of services. Ipsen is not responsible for the accuracy or completeness of any information or opinions set forth in the Materials. Expert advice reflects only the personal view of that expert, and in no case shall it be regarded as the opinion or responsibility of Ipsen.
   
   
4. Protection of Personal Data and Confidential Information
   
  a. Protection of Personal Data

Ipsen fully understands the importance of privacy and the protection of personal data in the digital era and is committed to ensure an adequate level of data protection for you. We invite you to read the Event Privacy Policy to get more information about the processing of your personal data. Ipsen is data controller for the processing of personal data collected through the Event.
   
  b. The Event is not designed to receive any confidential information which you may submit.

Consequently, and except for the personal data mentioned above, any information in whatever form - documents, data, graphics, questions, suggestions, concepts, remarks or other - which you communicate during the Event will in no way be deemed confidential. Consequently, the mere transmission by you gives us the right to use, reproduce, distribute, modify or transmit this information in order to process your request.
   
  c. Confidentiality – Restricted Use

You shall keep confidential, not disclose to any third party and shall use solely for the purpose of this Event all results, data, information, documents, products and materials provided or disclosed by Ipsen and or its affiliates and or its agents before, during or after the Event, or obtained by you in the Event, including without limitation information regarding Ipsen or its affiliates' products (the "Information"). These obligations of confidentiality and restricted use shall be in force for a period of ten (10) years following the date of the Event.
   
   
5. Limitations of liability
   
  Ipsen does not guarantee the accuracy, precision, updating or exhaustiveness of the information made available or presented during the Event.
The Materials are provided “as is”, without any kind of warranty, whether express or implied. Ipsen does not offer any express or implied warranty relative without limitation to their merchantability and fitness for a particular purpose.
   
   
6. Availability of the Event
   
  You acknowledge that (i) it is technically impossible that the Event will be provided free of defaults and that Ipsen cannot take any responsibility for this, (ii) that defaults may lead to the temporary unavailability of the Event or the Materials, and that (iii) the operation of the Event may be adversely affected by conditions and performances outside Ipsen’s control, such as, for example, transmission and telecommunication links between the Event and you and between the Event and other systems and networks.

Ipsen is not liable for any modification to or suspension or interruption of the Event.
   
   
7. Information on the products
   
  The information contained on the Material may contain direct or indirect references to products of Ipsen which are not proposed or available in certain countries or regions, or which may be offered under a different trademark, and which may be subject to different regulations and conditions of use according to the country. Such references do not imply any intention on the part of Ipsen to sell these products in your country. Please consult the local Ipsen affiliate or Ipsen local commercial partner for any information concerning the products which are available in your region / country.
   
   
8. Adverse events
   
  You undertake to inform Ipsen of any report of an Adverse Event or Product Complaint using the reporting process specified by Ipsen. Such reports will be submitted to the relevant Ipsen contact within 24 hours of the collection of the data. If applicable Ipsen may provide you with training in the collection of reports of Adverse Events and Product Complaints before the initiation of the Event.

During the course of the performance of the Event, you shall report to Ipsen any observable Suspected Adverse Event, Product Complaint or Report of Pregnancy that occurs or is detected by you with regard to an Ipsen Group medicinal product.

An Adverse Event (“AE”) is any unfavorable or unintended sign, symptom or disease associated with the administration of an Ipsen Group drug product, regardless of whether the reporter thinks that the drug might have caused the event. AEs may include but are not limited to: clinical signs, symptoms or diagnosis; Abnormal test results (e.g., blood tests, X-ray, ECG); drug interactions; drug overdose; drug abuse or misuse of the product; drug dependency or possible effects resulting from drug withdrawal; lack of efficacy (product does not work as expected) or loss of intended effect; medication errors; transmission of infectious agents; occupational exposure to drug; a worsening of a pre-existing condition; drug exposure via parent; unexpected benefits; off-label use.

A Product Complaint is any communication regarding the failure or defect in the drug product and/or its components (either real or perceived), to meet any of its specifications or standards of quality, purity, safety, identity, performance, potency. Examples of product complaints include, but are not limited to: a crack in a glass vial; the vial contents looked cloudy; no package insert in the carton; a cap was missing; no vacuum in vial when inserting needle; the needle was dull; or the syringe plunger was stuck.

Adverse Event and Packaging Quality Complaints Reports shall be sent to the Global Patient Safety Adverse Event mailbox : adverse.events@ipsen.com, or to the local PV pharmacovigilance.sg@ipsen.com.
   
   
9. Severability
   
  The invalidity or unenforceability of any provision of these Terms and Conditions shall not affect the validity or enforceability of any other provision, which shall remain in full force and effect, except where the invalidity or unenforceability relates to an essential term of these Terms and Conditions.
   
   
10. Governing laws and dispute resolution
   
  These Terms and Conditions and your use of the Event shall be governed by the laws of Singapore, except for the provisions of international private law.

Disputes that cannot be resolved amicably, will be submitted to the courts and tribunals of Singapore.
   
   


Last updated 23rd March 2021.

Copyright © 2021 Ipsen Pharma Singapore Pte Ltd, 20 Anson Road, #10-03 Twenty Anson, 079912 Singapore.

All Rights Reserved